Nativis is a biotechnology company focused on the development of innovative therapies for patients with serious diseases. Operating within the life sciences industry, the company specializes in novel drug delivery technologies aimed at improving treatment outcomes. Nativis primarily serves the medical and pharmaceutical sectors, providing solutions intended for healthcare providers and patients in need of advanced therapeutic options. Through its research and development efforts, the company contributes to the advancement of medical treatment modalities.